IAB is a Research Center jointly supported by the French National Institute of Health and Medical Research (Inserm 1209), by the The National Center for Scientific Research (CNRS 5309) and the Grenoble AlpesUniversity (UGA). Other stakeholders include Grenoble Alpes University Hospital (CHUGA) and the French Blood Transfusion Center (Etablissement Français du Sang, EFS).
IAB is an institute of international standing in basic and translational biomedical research. Its defining feature is the coverage of a range of scientific expertise across the biological continuum from molecules to populations. Founded in 1999 as Institut Albert Bonniot, IAB develops world-class programs in basic and translational biomedical research, enabling the new definition of its name as the Institute for Advanced Biosciences.
The scientific strategy of IAB is based on an unique blend of scientific expertises encompassing the entire biological continuum from molecules to populations and covering genetics, epigenetics and signaling through chromatin, cell biology and cell-matrix interactions, cell signaling, molecular pathology, host-parasite interactions, immunology and environmental epidemiology.
IAB is committed to scientific excellence and promotes an intense and dynamic collaborative culture, supporting risk-taking and cross-disciplinary research towards groundbreaking discoveries. IAB develops an international training and education program, welcoming graduate and post-doctoral students from all parts of the world, and supports career development for young, exceptionally bright scientists.
IAB promotes science without frontiers and shares an ambitious international agenda with partner research centers in Europe and around the world (Shanghai, China; Kuala Lumpur, Malaysia; Sao Paulo, Brazil; US).